Health Results Based Financing Impact Evaluation 2021 -2022, Health Facility Follow-Up Survey
Congo, Dem. Rep., 2021 - 2022
Get MicrodataCreated on
May 30, 2023
Last modified
May 30, 2023
Page views
81638
Downloads
881
[F1_1416_64] Traitement associé à base d'artémisine (Artésunate+ luméfantrine) A (f1_1416_64_1)
Data file: f1_facility_anon
Overview
Valid:
346
Invalid:
0
Minimum:
1
Maximum:
10
Type:
Discrete
Decimal:
0
Width:
15
Range:
1 - 10
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 1 | 1 comprimé | 2 |
0.6%
|
| 2 | ampoule | 1 |
0.3%
|
| 3 | plaquette 6 cp | 34 |
9.8%
|
| 4 | plaquette 12 cp | 11 |
3.2%
|
| 5 | plaquette 24 cp | 289 |
83.5%
|
| 7 | injectable | 1 |
0.3%
|
| 8 | comprimé | 3 |
0.9%
|
| 9 | plaquette 3 cp | 3 |
0.9%
|
| 10 | plaquette 18 cp | 2 |
0.6%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.